Qi-Jing Li

Conference Blood · November 13, 2019 Allogeneic hematopoietic cell transplantation is a potentially curative treatment choice for a wide variety of hematological malignancies. However, graft-versus-host disease (GVHD), which is mediated by donor alloreactive T cells, limits the succes ... Full text Cite

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma

Conference EUROPEAN JOURNAL OF IMMUNOLOGY · October 1, 2019 Link to item Cite

Eosinophils induced by radiation contribute to cytotoxic T lymphocyte recruitment and improve immunotherapy

Conference EUROPEAN JOURNAL OF IMMUNOLOGY · October 1, 2019 Link to item Cite

Erythroid progenitor cell reprogrammed to MDSC-like immune suppressive cells in late-stage cancer

Conference EUROPEAN JOURNAL OF IMMUNOLOGY · October 1, 2019 Link to item Cite

The mIR17-92 Cluster Promotes Costimulation Resistant Effector Memory T Cell-Mediated Alloresponses.

Conference AMERICAN JOURNAL OF TRANSPLANTATION · April 1, 2019 Link to item Cite

Abstract 2255: Using tumor sample gene expression data to infer tumor purity levels with stochastic gradient boosting machines

Conference Cancer Research · July 1, 2018 AbstractTumor purity is the percent of cancer cells present in a sample of tumor tissue. The noncancerous cells (stromal cells) in a tumor are thought to have an important role in tumor growth, metastatic pr ... Full text Cite

Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma.

Conference Journal of Clinical Oncology · May 20, 2018 Full text Cite

Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.

Conference Journal of Clinical Oncology · May 20, 2018 Full text Cite

Effector CD4⁺ T cells can convert to a CD8⁺, MHCII-restricted T cell lineage

Conference JOURNAL OF IMMUNOLOGY · May 1, 2017 Link to item Cite

Tumor stem cell RNA-leaded dedritic cell vaccine for recurrent glioblastoma: a phase 1 trail.

Conference Neurology · April 27, 2017 Objective: To evaluate the feasibility and safety of administering brain tumor stem cell (BTSC) mRNA-loaded dendritic cells (DC) to patients with recurrent GBM. Background: BTSC CD133+ contribute to GBM propagation and are associated with chemo-radiation ... Link to item Cite

Host Lymphopenia Enhances the Abundance, Activation Status, and Antitumor Efficacy of Tumor-specific T Cells Delivered Directly into the Brain

Conference JOURNAL OF NEUROSURGERY · April 1, 2017 Link to item Cite

Extracellular Mitochondria Cause B7 Costimulation Blockade Resistant Allograft Rejection in Mice

Conference AMERICAN JOURNAL OF TRANSPLANTATION · April 1, 2017 Link to item Cite

Evaluation of Function and TCR signaling Profile of CD57+T Cells in Allo-Specific Immunity

Conference AMERICAN JOURNAL OF TRANSPLANTATION · April 1, 2017 Link to item Cite

LYMPHOPENIA ENHANCES THE EFFICACY OF CAR T CELLS DELIVERED LOCO-REGIONALLY IN THE BRAIN FOR THE TREATMENT OF GLIOBLASTOMA

Conference NEURO-ONCOLOGY · November 1, 2016 Link to item Cite

Qi-Jing Li

Scholarly Works - Conferences

MTOR Inhibition Acts Directly on Endothelial Cells to Induce Contact-Independent Immune-Modulation of Allo-Specific T Cell Activation.

CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY

Mitochondrion-Endothelial Interaction Generates Danger Signal in Promoting Costimulation-Resistant T Cell-Mediated Allograft Rejection

Microrna-191 Regulates T-Cell Clonal Expansion during Graft-Versus-Host Disease

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma

Eosinophils induced by radiation contribute to cytotoxic T lymphocyte recruitment and improve immunotherapy

Erythroid progenitor cell reprogrammed to MDSC-like immune suppressive cells in late-stage cancer

The mIR17-92 Cluster Promotes Costimulation Resistant Effector Memory T Cell-Mediated Alloresponses.

Abstract 2255: Using tumor sample gene expression data to infer tumor purity levels with stochastic gradient boosting machines

Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma.

Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.

Effector CD4⁺ T cells can convert to a CD8⁺, MHCII-restricted T cell lineage

Tumor stem cell RNA-leaded dedritic cell vaccine for recurrent glioblastoma: a phase 1 trail.

Host Lymphopenia Enhances the Abundance, Activation Status, and Antitumor Efficacy of Tumor-specific T Cells Delivered Directly into the Brain

Extracellular Mitochondria Cause B7 Costimulation Blockade Resistant Allograft Rejection in Mice

Evaluation of Function and TCR signaling Profile of CD57+T Cells in Allo-Specific Immunity

LYMPHOPENIA ENHANCES THE EFFICACY OF CAR T CELLS DELIVERED LOCO-REGIONALLY IN THE BRAIN FOR THE TREATMENT OF GLIOBLASTOMA

IMST-38. CAR T CELLS INDUCE COMPLETE REGRESSION OF MURINE GLIOBLASTOMA AFTER PRECONDITIONING HOSTS WITH TEMOZOLOMIDE

A new genetic model for separating and analyzing Treg cells in unchallenged mice based on their proliferative history

Targeting miR-23a in CD8⁺ cytotoxic T lymphocytes for tumor immunotherapy

LAT-independent triggering of granule-mediated cytotoxicity of CD8 T cells

Distinct populations of CD4+helper T cells generate CD4 and CD8 memory responses to infection

Presentation of similar images for diagnosis of breast masses on mammograms: analysis of the effect on residents